London and Leicester, United Kingdom, and Iasi, Romania
The incidence of peanut allergy (PA) has increased over the last decades so that its prevalence in childhood is currently estimated at 1.4% 1 in the United States and reaches 1.8% in the United Kingdom. 2, 3 Because PA is rarely outgrown and is responsible for a significant proportion of severe anaphylactic reactions to foods, it represents a major population health concern. 4 Mechanistically, PA is driven by T H cells, the determinant role of which was confirmed by the observation that allergy can be transferred from donors with PA to children without peanut allergy (NA children) through solid organ transplantation, which entails T H cell transfer. 5 Conversely, PA resolution has been observed after bone marrow transplantation. 6 We 7 and others 8, 9 showed that the in vitro peanut-specific T H cell response in patients with PA is dominated by a T H 2-polarized population characterized by the production of T H 2 cytokines, such as IL-4, IL-5, and IL-13. However, we also observed that a significant number of in vitro peanut-responding T H cells did not produce T H 2 (nor T H 1-specific) cytokines, even when restimulated with phorbol ester and calcium ionophore, suggesting that they might belong to distinct T H cell subsets. 10 Indeed, the discovery of regulatory T (Treg), T H 17, T H 22, and, more recently, T H 9 cells shows that T H cell responses go beyond the binary T H 1/T H 2 paradigm. 11 Treg cells suppress IgE production 12 and block mast cell, basophil, and eosinophil activation, 13 whereas in mouse models of asthma, T H 17 cells increase eosinophilia and IgE production. 14 T H 9 was recently identified as a distinct T H cell subset induced by the combination of IL-4 and TGF-b. 15 IL-9, which is the T H 9 subset-defining cytokine, is a mast cell growth factor that increases cytokine production in activated mast cells and enhances IL-4-driven IgE production by B cells. IL-9 is highly expressed in the lungs of asthmatic human subjects, 16 and in an experimental mouse model neutralizing anti-IL-9 antibodies were shown to ameliorate T H 9-mediated asthma. 17, 18 In the present study we aimed to further dissect the peanutresponding T H cell subsets by separating the skin-homing T H cells, which express the cutaneous lymphocyte antigen (CLA), 19 and the gut-homing memory T H cells, which express the a 4 b 7 integrin (B7) gut-homing marker, respectively. 20 Skin exposure to peanut antigens after skin stripping to mimic an eczema phenotype leads to strong T H 2-skewed responses in mice, supporting the concept of epicutaneous sensitization. 21 Furthermore, we recently showed that peanut-specific proliferation is quantitatively higher in the skin-homing than guthoming T H cells in patients with PA. 22 Conversely, oral exposure to antigens underlies oral tolerance and is associated with higher levels of antigen-specific proliferation of gut-homing T cells. 20 This has led to the dual-allergen exposure hypothesis being proposed in that the timing and balance of cutaneous versus oral exposure to an allergen might determine whether the child has allergy or tolerance. 23 In this study we aimed to assess differential gene expression in PBMCs cultured with peanut from children with PA, children with PS, and NA children in both skin-and gut-homing T H cells and fluorescence-activated cell sorting (FACS) analysis of intracellular cytokine production.
METHODS

Study participants
Donors with PA, donors with PS, and atopic NA donors were recruited from a tertiary referral allergy center at St Thomas Hospital Children's Allergy Unit, London, United Kingdom. Informed consent was obtained before participation. Ethical approval for this study was obtained from the St Thomas Research Ethics Committee (reference 10/H0802/45). Three children with PA and 3 atopic NA children were recruited for gene expression analysis, and 36 microarrays were carried out on various T-cell populations derived from their peanut-stimulated and unstimulated PBMCs (as negative controls). Participants recruited for the gene microarray work were all male to avoid differential gene expression linked to sex. Forty patients recruited for subsequent real-time quantitative PCR (RT-qPCR) and FACS analysis did not have sex as a selection criterion. PA was defined as having a convincing history of an immediate hypersensitivity reaction after exposure to peanut and a skin prick test response to peanut extract of 8 mm or greater or a peanut-specific IgE level of 15 kU/L or greater. 24 Peanut tolerance was defined as regular peanut consumption (ie, eating an age-appropriate amount of peanut in 1 meal without any allergic symptoms within the last month); some of these subjects had PS, as defined by an SPT response of 3 mm or greater or a peanutspecific IgE level of 0.35 kU/L or greater. If there was no history of peanut consumption, children underwent a double-blind, placebo-controlled food challenge. The demographic and clinical characteristics of all study participants are described in Table E1 in this article's Online Repository at www.jacionline.org.
Details of the methodology are described in the Methods section in this article's Online Repository at www.jacionline.org.
Overview of methods
PBMCs from 3 children with PA and 3 NA children were cultured with peanut antigens for 18 hours. Subsequently activated (CD69 
RESULTS
Microarray analysis of gene expression in peanutactivated memory T H cells from donors with PA versus NA donors
The level of gene expression in peanut-activated memory T H cells from donors with PA and atopic NA donors is displayed as a volcano plot by using the Partek Genomics Suite (Fig 1) ; the horizontal axis shows the fold-change difference of gene expression between children with PA and NA children, whereas the vertical axis displays the statistical significance of the difference of gene expression between children with PA and atopic NA children, taking into account gene expression variability within the children with PA and the NA children groups, respectively. The genes appearing in the top right area were upregulated in children with PA versus NA children; the most statistically significant differently expressed gene was IL9 (45.59-fold change, P < .001), followed by the T H 2 gene cluster containing IL5 and IL13. Conversely, the genes appearing in the top left area (eg, SULT1B1 and RGS18) were upregulated in atopic NA donors. Peanut-specific memory T H cells from donors with PA express typical T H 2-specific genes, as well as T H 9-associated genes A hierarchical clustering heat map of the data set (Fig 2) consisting of 48 differentially expressed genes selected through a filter criteria of at least 2-fold changes of expression with a P value of less than .05 was produced with the Partek Genomics Suite. There was notable differential expression between peanut-stimulated activated (CD69 25 Chemokine (C-C motif) ligand 1 (CCL1), IL31, and IL3 were preferentially expressed in skin-homing T H cells from donors with PA. Other genes differentially expressed in children with PA versus NA children and their functions and involvement in allergy are described in Table I . [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] Most genes preferentially expressed in NA children versus children with PA were as yet not functionally understood, and only SULT1B1, GCNT4, and RGS18 could be identified (Table I) .
ANOVA of genes expressed in T H subsets from PA and NA children To compare the basal nonstimulated level of gene expression in skin-and gut-homing peanut-activated memory T H cells, we performed 36 microarrays (displayed in Table E2 2 T H cells) in donors with PA and NA donors had low expression of all genes assessed. There was very little background expression of IL9, IL4, IL5, IL13, IL31, and CCL1 in internal negative controls (peanut-stimulated CD69 2 cells) in PA and NA donors; however, there was some background expression of IL17RB, IRF4, and CISH in peanut-stimulated CD69
2 T H cells (see Fig E4) .
IL9 allows differentiation between children with PA and NA children when used in the frame of a random forest classifier
We used a random forest (RF) algorithm to classify the peanutstimulated activated (CD69
1
) T H cell responses in children with PA versus NA children. We built 250, 500, and 750 trees (analysis pathways); the number of analysis pathways is dictated by a tradeoff between the efficiency (computing speed and memory consumption) of the classifier and the quality of its predictions. By using this approach, RF was able to differentiate between children with PA versus NA children with 100% accuracy, even when the gene selection was limited to sets of 10, then 5, and then only 2 genes. In this final analysis the 2 genes that are able to accurately distinguish between PA and NA samples were IL9 and HSPA5 for 250 trees, IL9 and 8069610 for 500 trees, and IL9 and HUWE1 for 750 trees (Fig 4) . From these sets of genes, IL9 expression was the best discriminating gene between memory T H cells from children with PA and NA children. Differential gene expression of T H 2 and T H 9 cytokines between children with PA and NA children is confirmed by using RT-qPCR Expression of IL5 and IL13 (signature genes for T H 2 responses) and IL9 and IRF4 (reflecting T H 9 responses), respectively, was higher in PBMCs isolated from donors with PA than in those from NA donors (Fig 5) (11. 89-fold difference). Thus IL9 had the highest fold differential gene expression between donors with PA and NA donors. Significant differential gene expression (RQ) was also observed for other genes known to be involved in allergic responses, such as IL31, CISH, and CCL1 (P <.01) and the T H 2/T H 9-specific transcription factor IRF4 (P < .05). On RTqPCR analysis, there was no significant differential IL4 and IL17RB expression between donors with PA and NA donors.
Differential gene expression of T H 2 and T H 9 cytokines between children with PA and children with PS by using RT-qPCR
After the finding that IL9 had the highest differential expression in children with PA versus NA children, we sought to determine whether this would also be a useful biomarker to differentiate between children with PA and children with PS ( Fig 5) 22 .86) in children with PS (7.14-fold difference). Thus IL9 also had the highest fold differential gene expression between donors with PA and donors with PS. CCL1, CISH, and IL31 were also differentially expressed between donors with PA and donors with PS. One child with PS who was eating whole peanuts 1 to 2 times per month had higher IL9, IL5, and IL31 gene expression levels, which is represented by the green points for these 3 RQ box plots (Fig 5) .
Different T H populations secrete IL-9 and IL-5 cytokines
ICCS of peanut-stimulated memory T H cells demonstrated that IL-5 and IL-9 are produced by distinct T H cell subsets (Fig 6 and  see Table E3 in this article's Online Repository at www. jacionline.org); memory T H cells from all donors with PA produced more IL-9 and IL-5 than those from children with PS, and the pattern of cytokine expression was mutually exclusive.
DISCUSSION
We used the well-established Affymetrix microarray method to determine gene expression profiles of memory T cells responding to peanut antigens in vitro to characterize differential gene expression and the different T H cell subsets involved in PA. Microarray gene expression data found evidence of high IL9 expression in activated memory T H cells from donors with PA in addition to the expected T H 2 gene signature. Applying an RF algorithm, we found that IL9 was the best gene classifier that allows differentiation between children with PA and NA children with 100% accuracy. Using RT-qPCR and FACS, we confirmed the presence of IL9 at a gene and protein level and showed that IL9 was the best gene to distinguish between children with PA and NA children (23.3-fold difference), as well as between children with PA and children with PS (18.5-fold difference), thus making IL9 a good biomarker for clinical PA in this study. The differential expression of T H 2 signature genes (IL5 and IL13) and T H 9-associated genes (IL9 and the transcription factor IRF4) in children with PA versus NA children, as well as the dichotomous pattern of IL5 and IL9 production in peanut-stimulated activated memory T cells suggests the involvement of both T H 2 and a distinct T H 9 subset in children with PA.
Jabeen and Kaplan 41 reviewed the recently discovered T H cell subset T H 9, which produces IL-9 but not the other T H 2-defining cytokines, such as IL-5 and IL-13. T H 9 cells have been described in the inflamed skin of patients with atopic eczema 42 and in the bronchial mucosa in mouse models of allergic asthma, 16 and T H 9 is emerging as an important T-cell subset in human respiratory allergic disease. 15 ,41 IL9 has previously been described as the top-ranking gene (from 1482 differentially expressed genes) for discriminating between atopic and nonatopic responses to house dust mite. 37 IL-9 production is also important for in vivo allergic responses in patients with seasonal allergic rhinitis because successful specific immunotherapy with grass pollen led to the decrease in IL9 mRNA and IL-9 protein levels in the 
IL17RB
.0410 IL17RB binds IL-17B and IL-17E (IL-25). IL-17 amplifies delayed-type reactions by increasing chemokine production to recruit monocytes and neutrophils to the site of inflammation.
34
MS4A3
.0486 Membrane-spanning 4-domains subfamily A, member 3, likely plays a role in signal transduction in lymphoid cells. MS4A3 levels are increased in patients with latex allergy, vegetable food allergy, or both. 35 Genes are listed in order of statistical significance. All genes were upregulated in children with PA versus NA children, except SULT1B1, GCNT4, and RGS18, which were upregulated in NA children versus children with PA. patients' nasal mucosa. 43 IRF4 is necessary for the differentiation of T H 9 cells 29, 30 and has previously been described by using gene expression microarrays in allergen-stimulated PBMCs from patients with allergic rhinitis. 44 In mice, oral antigen-induced anaphylaxis to ovalbumin (OVA) is IgE mediated and predominantly IL-9 and IL-9 receptor pathway dependent. 45 Il9 2/2 and Il9r 2/2 mice had OVAspecific IgE levels after intraperitoneal OVA/alum immunization but did not have anaphylaxis after OVA oral gavage and had reduced intestinal mast cell proliferation and degranulation. This might explain the role of IL-9 in IgE-mediated food allergy versus only IgE-specific sensitization.
In a recent study in human subjects, IL9 was the best gene to discriminate between peanut-stimulated PBMCs from adults with PA versus NA children (28-fold difference on RT-qPCR); however, IL9 expression was not assessed in adults with PS. 46 Other differences between that article and ours were that (1) they assessed adults rather than children; (2) their peanuttolerant group were generally nonatopic, whereas the majority of our peanut-tolerant group was atopic, thus accounting for genes upregulated because of atopy rather than PA per se; (3) exploratory microarray analysis was not used to determine candidate genes, and thus other important differentiation genes might have been excluded; and (4) IL9 gene expression was initially investigated in the entire PBMC population rather than in different T-cell subsets to determine which cells were producing IL-9. However, importantly, they showed significantly increased IL-5 and IL-9 levels in the 5-day peanut culture supernatants of children with PA versus NA children (by using ELISA).
We confirmed differential gene expression between children with PA and NA children for IL9 and its transcription factor IRF4, signature T H 2 genes (IL5 and IL13), and other genes important for allergen-specific responses (CISH, IL31, and CCL1) using RTqPCR. Confirmation of microarray findings was performed with RT-qPCR of whole PBMCs rather than FACS-sorted cells because if IL-9 is to be useful as a diagnostic biomarker, then it should be able to distinguish between patients with PA and NA subjects in unseparated cells rather than in very small T H cell subsets that involve cumbersome experimental procedures requiring highly skilled personnel. The IL-25 receptor (IL17RB) and IL4 were no longer significantly differentially expressed between children with PA and NA children on RT-qPCR. The IL-25 receptor (IL17RB) is expressed in T H 9 cells generated in vitro in the presence of TGF-b and IL-4. 47 The difference between findings in the microarray and RT-qPCR might be because the microarray was performed on peanut-cultured activated memory T H cells, whereas the RT-qPCR was performed on whole PBMCs, and thus the signal might not be as strong in a mixed cell culture. Furthermore, on microarray analysis, IL17RB and IL4 were not as highly differentially expressed as IL9, IL5, and IL13 in children with PA versus NA children (Fig 1) . CISH was upregulated in children with PA versus NA children and children with PS and has been shown to be differentially expressed in house dust mitestimulated T cells from atopic subjects versus nonatopic subjects 37, 48 and in OVA-stimulated PBMCs from patients with egg allergy versus those without egg allergy. 40 A notable finding in this study was the lack of differential expression of T H 2-and T H 9-related genes between skin-and guthoming memory T H cell subsets in children with PA, given our previous findings. 22 Additionally, there was no significant difference in the number of CLA 1 versus B7 1 activated memory T H cells sorted from peanut-stimulated culture in children with PA versus NA children, although there was a trend toward higher responses to peanut from the gut-homing versus skin-homing memory T H subset in NA donors (P 5 .05). One potential explanation for this is that the children with PA who we investigated had longterm, well-established PA; therefore it is plausible that although the original T H 2 and T H 9 gene expression profile might have been limited only to the skin-homing T H cell subset, in the long term the T H 2 and T H 9 responses became dominant in all lymphocyte-homing compartments as a consequence of allergic subjects' repeated exposure to peanut, either through eczematous skin or accidental oral exposure. Future experiments could further identify the differences between peanut-specific immune responses of skin-and gut-homing subsets in children with PS if this were carried out longitudinally in a prospective approach as the children progress from PS to PA.
Nonetheless, other genes were differentially expressed in skinversus gut-homing T H cells; CCL1, IL31, and IL3 were upregulated in skin-homing T H cells from donors with PA compared with gut-homing T H cells from donors with PA and gut-and skin-homing T H cells from NA donors. CCL1 is secreted by activated T cells and IgE-activated human mast cells and binds to the CCR8 receptor expressed by T H 2 cells, dendritic cells, monocytes, natural killer cells, and immature B cells. 41 Notably, CCR8 is expressed by approximately 70% of T H cells recruited in the airways of asthmatic subjects, which is why oral forms of the small-molecule CCR8 antagonists are currently being developed for therapeutic purposes.
39 IL31 is produced mainly by activated T H 2 cells, and its levels are increased in skin biopsy specimens of patients with eczema and contact dermatitis. 25 IL3 increases the activation and release of mediators from eosinophils and basophils in response to IgE FCεRI cross-linking. The differential expression of these genes reflects the contrast between the skin-and gut-homing T H cell subsets observed in the primary component analysis (PCA; see Fig E3 in this article's Online Repository at www.jacionline.org); however, the differential expression of homing-related genes was not mirrored by a differential expression of T H 2 and T H 9 subset-defining cytokine genes. The lack of such a difference suggests that in patients with wellestablished PA, allergen-specific T-cell populations comprise T H 2 and T H 9 cells, regardless of their homing phenotype.
Another unexpected finding was the absence of an identifiable Treg gene signature in the peanut-responding memory T H cells from NA donors; however, the microarray did identify 3 genes, SULT1B1, GCNT4, and RGS18, and other as-yet-unidentified genes that were differentially expressed in NA children versus children with PA. The absence of classical Treg cell biomarkers suggests that a suppressor cytokine environment is not actively induced after only short-term (18-hour) in vitro stimulation with antigens from tolerated foods. Another potential explanation for this finding is that peanut-specific (CD69 1 ) Treg cells in NA children do not express CLA or B7 homing markers and were thus not gated and isolated on FACS analysis.
In this study IL9 was the best discriminator for children with PA versus NA children and also, importantly, children with PS. Mutually exclusive production of T H 9-specific (IL-9) and T H 2-specific (IL-5) cytokines suggest that IL-9-producing cells belong to the distinct T H 9 subset population. The use of gene expression microarrays to generate hypotheses by evaluating the overall immune response to an allergen in a small number of patients, followed by further in-depth investigations, has previously been successfully applied to elucidate the mechanisms underlying peanut oral immunotherapy 49 and for predicting the efficacy of venom immunotherapy. 50 Future research into the interplay between the T H 9 and T H 2 subsets might clarify whether the success of preventative therapeutic approaches aimed at PA resolution could be evaluated on the basis of IL-9 secretion and/or T H 9 suppression in peanut-specific in vitro responses. Prospective studies should further evaluate IL9 as a biomarker for PA and as a potential target for the prevention and treatment of PA.
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Clinical implications: The IL9 gene might be a useful biomarker to distinguish between children with PA and children with PS. Further prospective studies are required to validate these findings and determine whether IL9 responses could be targeted in treating and preventing PA.
METHODS PBMC isolation and peanut stimulation in vitro
Anticoagulated blood was centrifuged for 5 minutes at 620g at room temperature to collect autologous plasma. After the plasma layer was collected, cells were diluted with a volume of PBS equal to the volume of plasma removed and then decanted into cell-separation tubes over a Histopaque-1077 layer. These were centrifuged at 1200g for 15 minutes at room temperature, and then the PBMCs at the interface were collected and washed 3 times with PBS. PBMCs were counted with a Nucleocounter and then resuspended in serum free AIM V medium (containing 10 mg/mL gentamicin sulfate and 50 mg/mL streptomycin sulfate) plus 2-mercaptoethanol (both from InvitrogenLife Technologies). PBMCs were cultured for 18 hours to detect the early allergen-specific response, as previously described.
E1 Cells were distributed in 24-well plates at a concentration of 3 million cells in 1 mL per well to ensure optimal cell-to-cell contact E2 and were either unstimulated or stimulated with 200 mg/mL whole defatted peanut protein extract (ALK-Abell o, Hørsholm, Denmark).
Cell labeling and flow cytometric sorting
Cells were aspirated from the peanut-stimulated and unstimulated cultures, respectively, and washed and stained on ice for 20 minutes with antibodies specific for CD4 as a T H cell marker (CD4-allophycocyanin; BD Biosciences, Oxford, United Kingdom) and CD45RO as a memory cell marker (CD45RO-Pacific Blue; BioLegend, London, United Kingdom). CLA, which is an adhesion molecule expressed by skin-homing cells, was used as a skin-homing marker (CLA-fluorescein isothiocyanate, BioLegend). b7 integrin, which is expressed by gut-homing cells, was used as a gut-homing marker (B7-PerCP/Cy5.5, BioLegend). CD69 labeling (CD69-PECy7, BioLegend) was used as a marker of cell activation to identify peanut-responding cells because its expression is rapidly upregulated on T cells after activation and remains stable for up to 72 hours.
E3 Thus skin-and gut-homing, activated and nonactivated memory T H cells (ie, CD4
1 CD45RO
, respectively) were 4-way sorted from both peanutstimulated and unstimulated PBMCs cultures with a FACSAria II Cell Sorter (BD Biosciences, San Jose, Calif). We display the FACS experiments for all 3 donors with PA and 3 NA donors in Fig E1 . Selected cells were sorted directly into TRIzol LS Reagent (Life Technologies) with a 3:1 ratio of TRIzol LS Reagent to volume of sample. Samples were vortexed and stored at 2808C until RNA extraction was performed. The number of cells undergoing FACS for each condition is displayed in Table E2 .
RNA extraction
RNA was extracted with the miRNeasy Mini kit (Qiagen), according to the manufacturer's protocol, by using TRIzol LS instead of QIAzol. We performed a DNase digestion step to remove any traces of contaminating DNA and carried out water elution of the RNA from the column twice to enhance the RNA yield. The amount and quality of RNA and cDNA obtained from the FACS-sorted cells from donors with PA and NA donors are displayed in Table E2 .
cDNA synthesis
The quality and quantity of total RNA were first examined on an Agilent 2100 Bioanalyser with the Agilent RNA 6000 Pico Kit (Agilent Technologies, Wokingham, United Kingdom). On confirming that the RNA integrity was of good quality, cDNA was synthesized with the NuGEN Ovation Pico WTA system v2 kit, according to the manufacturer's protocol. Briefly, 500 pg to 50 ng of total RNA in 5 mL of water was reverse transcribed into first-strand cDNA. Second-strand cDNA was then synthesized, which served as a template for amplification of transcripts through a proprietary Ribo-SPIA amplification step.
cDNA fragmentation, biotin labeling, and hybridization Three micrograms of amplified cDNA was fragmented and biotin labeled with the NuGEN Encore Biotin Module, according to the manufacturer's protocol. The hybridization cocktail was then prepared from the fragmented biotin-labeled cDNA by using the Affymetrix Hybridization, Wash and Stain kit and hybridized to the Affymetrix GeneChip Human Gene 1.0 ST Array for 18 hours at 458C and 60 rpm rotation. On completion of hybridization, washing and staining steps were performed on an Affymetrix GeneChip Fluidics Station 450, and arrays were scanned with an Affymetrix GeneChip 3000 7G scanner.
Microarray data normalization and quality checks
A robust multichip average method was used for data normalization. The array signal before and after normalization is shown in Fig E2, Ai and Aii. All arrays passed the basic quality checks, including a uniform hybridizing signal of the spike-in hybridization control at the staggered concentration of CreX > BioD > BioC > BioB (Fig E2, B) and a high positive versus negative area under the curve (''pos_vs_neg_auc'') that ranged between 0.82 and 0.90 (data not shown). PCA of peanut-induced gene expression was carried out with the Partek Genomics Suite software on normalized data from the peanut-activated memory T H cells (n 5
1 samples] microarrays in NA children).
PCA shows the variation in all the genes expressed in one 3-dimensional image. The Partek software took all genes (variables) and plotted them against each other, then ranked genes into orders of variability (ie, genes that do not change very much are ranked low and genes that do change are ranked high). Genes were then assembled into groups of genes with similar variability of variation. Groups of genes with the most variability were grouped together (PC1), followed by PC2 then PC3. Thus the PCA resulted in 3 arms of groups of genes based on the variability of gene expression and the similarity of patterns of gene expression. 
Partek Suite analysis of microarray
To create a heat map of differentially expressed genes, we used a 4-way ANOVA with peanut allergic status, T H homing (skin vs gut), donor (to adjust for donor effect), and date of microarray (to adjust for batch effect). The heat map (Fig 1) was based on all genes with 2-fold differential expression and a P value of less than .05. The actual P values obtained by using this 4-way AN-OVA are described in Table I , and box plots for individual differential gene expression are shown in Fig 3. To perform a detailed analysis of differential gene expression in the 36 PA and 36 NA samples (including internal and external negative controls), we subsequently used a 6-way ANOVA using stimulation (peanut stimulated versus unstimulated), both CD69 1 activation status and PA status, T H homing (skin vs gut), donor, and date of microarray. The box plots for individual gene expression using the 6-way ANOVA analysis are displayed in Fig E4. 
Microarray gene expression classification approach
Microarray data were analyzed by using an automatic classification approach, as currently used in data-mining/machine-learning fields; in these types of analyses the number of samples to be worked on is usually much larger than the number of data points (''features'') used to describe those samples. Because in our study the number of genes (features) in each microarray (n 5 32,020) was much larger than the number of microarrays (n 5 36 [samples]), a basic filter was first applied based on the fact that most genes show very small variability in their expression levels because they are involved in the basal cellular metabolism. The IQR of individual gene expression in all 6 patients (3 children with PA and 3 NA children) was used to identify those genes with expression levels that vary most between the PA and NA phenotypes. The global IQR of gene expression in each microarray was also calculated, and any genes with a variability of less than 20% of that value were removed. This filter was applied by using the open-source statistical software R (www.r-project.org/), and it narrowed down the analysis from 32,020 to 12,257 genes, representing about one third of all genes. (Fig 4) .
Using this set of 12,257 differentially expressed genes, RF, E4 which is a state-of-the-art supervised classification algorithm, together with recursive feature elimination, was used to classify all the peanut-activated samples into PA versus NA groups. The RF classifier is an ensemble of multiple classification trees (analysis pathways) and is suitable for our analysis with only 6 samples because its performance is estimated directly, without the need for cross-validation, by the out-of-bag error fraction. The accuracy of each set of genes compared between samples was computed by subtracting this error from 1, its maximum value. Recursive feature elimination is an algorithm used to select a subset of relevant data points or ''features'' (eg, gene expression levels) for use in model construction; it is usually used with support vector machines to repeatedly remove features with low weights when constructing a classification model. E5 An advantage of RF is the fact that it can measure each gene's (''feature's'') importance relative to the classification task at hand. Although there are several kinds of such importance measures, the unscaled permutation importance was used in this case because it is recommended for feature selection. E6 For each gene, it measures the decrease of classification accuracy in the case of random permutation of its expression levels averaged over all trees. The feature selection process that we used in combination with the algorithm is itself a recursive meta-algorithm in which, at each step, a random forest of decision trees was grown and then 50% of the genes (ie, those with the smallest differential gene expression level) were discarded. For a given sample, at each step of the classification process, a feature (ie, gene) was analyzed, and based on its value, a decision was reached to assign that sample to a certain class. The gene selection stopped when the number of remaining genes in the set used for classification decreased to less than a certain initially fixed threshold. All classification tasks were performed with the free software package Random Jungle. E7 RT-qPCR confirmation of gene expression RNA was extracted from peanut-stimulated PBMCs obtained from an independent group of 12 donors with PA and 18 peanut-tolerant donors (of whom 12 had PS) to confirm the microarray findings. Briefly, PBMCs were cultured for 18 hours in serum free AIM V medium (as described above) in the presence of 200 mg/mL whole defatted peanut protein extract (ALK-Abell o) or without any peanut antigen added (as an unstimulated negative control). RTqPCRs were performed with the following TaqMan MGB probes (Applied Biosystems, Invitrogen, Paisley, United Kingdom), as previously described: E8 IL3, Hs00174117_m1; IL4, Hs00929862_m1; IL5, Hs00174200_m1; IL9, Hs00174125_m1; IL13, Hs00174379_m1; IL31, Hs01098710_m1; CCL1, Hs00171072_m1; CISH, Hs00367082_g1; IRF4, Hs01056533_m1; IL17RB, Hs00218889_m1; and 18s rRNA, 4319413E. Target gene expression levels were compared against endogenous control 18s ribosomal RNA (DCT) and then against the peanut-unstimulated control (DDCT) and converted to RQ (2
2[DDCT]
). Genes with no amplification were assigned a cycle threshold value of 40. The Mann-Whitney test was performed to compare RQ values between NA children and children with PA and between children with PS and children with PA by using SPSS (SPSS 19.0; SPSS, Chicago, Ill).
FACS analysis of intracellular cytokine production
After results obtained from the gene microarray and RT-qPCR, we sought to confirm our gene expression findings on a protein expression level. PBMCs from 5 donors with PA and 5 donors with PS were cultured overnight in RPMI 1640 supplemented with 5% autologous plasma in the presence of 200 mg/mL whole defatted peanut protein extract (ALK-Abell o) or without any antigen added (as an unstimulated negative control) in the presence of monensin (2 mg/ mL) and brefeldin A (1 mg/mL) as inhibitors of cytokine secretion. After incubation, PBMCs were fixed, permeabilized, and stained with antibodies specific for CD4, CD45RO, CLA, B7, IL-5, and IL-9, and cytokine production (IL-5 and IL-9) was analyzed by using FACS. IL-5 was used to identify T H 2 cells, whereas IL-9 was used as the hallmark cytokine to identify the T H 9 subset. 
FIG E2.
Data normalization and quality checks for microarray hybridization. Box plots of array hybridization signal before and after robust multichip average (RMA) normalization are shown in Fig E2 , Ai and Aii, respectively. All arrays had a uniform pattern of hybridization control signal (Fig E2, B) , which was at the expected intensity in congruence with their staggered concentration of CreX > BioD > BioC > BioB. Red, CreX; blue, BioD; pink, BioC; and green, BioB. 
